Somatically mutated ABL1 is an actionable and essential NSCLC survival gene

The lack of actionable mutations in patients with non‐small cell lung cancer (NSCLC) presents a significant hurdle in the design of targeted therapies for this disease. Here, we identify somatically mutated ABL1 as a genetic dependency that is required to maintain NSCLC cell survival. We demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Testoni, Ewelina, Stephenson, Natalie L, Torres‐Ayuso, Pedro, Marusiak, Anna A, Trotter, Eleanor W, Hudson, Andrew, Hodgkinson, Cassandra L, Morrow, Christopher J, Dive, Caroline, Brognard, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734836/
https://www.ncbi.nlm.nih.gov/pubmed/26758680
http://dx.doi.org/10.15252/emmm.201505456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734836/
https://www.ncbi.nlm.nih.gov/pubmed/26758680
http://dx.doi.org/10.15252/emmm.201505456

Ejemplares similares